Loading...

Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital

BACKGROUND: Living donor liver transplantation (LDLT) is an established treatment not only for those with end-stage liver disease but for those with hepatocellular carcinoma (HCC) developing in cirrhotic liver. The aim of this study was to present a single-center experience of LDLT for HCC at the Un...

Full description

Saved in:
Bibliographic Details
Published in:Hepatobiliary Surg Nutr
Main Authors: Togashi, Junichi, Akamastu, Nobuhisa, Kokudo, Norihiro
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2016
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5075828/
https://ncbi.nlm.nih.gov/pubmed/27826554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2016.08.05
Tags: Add Tag
No Tags, Be the first to tag this record!